A new study revealed that ELAVL4 influences multiple biological pathways linked to Alzheimer’s disease, including those involved in synaptic function and the expression of genes downstream of APP and tau signaling [45]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.